Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.96 USD
Change Today +0.0106 / 1.12%
Volume 187.6K
CYCC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth R. Harrap CBE, Ph.D., DSc, FRSC, SAB

Member of Scientific Advisory Board, Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Prof. Kenneth R. Harrap, CBE Ph.D. DSc FRSC SAB, served as Clinical and Scientific Advisor at Twinstrand Therapeutics, Inc. Prof. Harrap served as Director of the CRC Centre for Cancer Therapeutics, a multidisciplinary unit responsible for the discovery and development of new anticancer drugs, at the institute of Cancer Research, Sutton, United Kingdom until September 1997. He has formed collaborations with the pharmaceutical industry that have led to the clinical development, ...

Read Full Background

Corporate Headquarters*

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1961
University Of London
ScD 1997
University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.96 USD +0.0106

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.